Serum lipidome remodeling in viral pneumonia: from pathophysiology to therapeutics
-
By
-
Yige Wang
-
Qiang Xiao
-
June 22, 2026
-
Clinical Scorecard: Lipidomic Changes in Viral Pneumonia: Insights into Pathophysiology and Treatment Approaches
At a Glance
| Category | Detail |
|---|
| Condition | Viral Pneumonia |
| Key Mechanisms | Radical remodeling of the host lipidome, including significant declines in LDL-C and HDL-C, and activation of ferroptotic cell death. |
| Target Population | Patients with severe viral pneumonia, particularly those at risk for ARDS. |
| Care Setting | Clinical settings managing severe respiratory infections. |
Key Highlights
- Severe viral pneumonia is characterized by a systemic 'metabolic crash' and lipidomic storm.
- Lower LDL-C levels at admission correlate with more severe disease and worse outcomes.
- ApoA-I and HDL particles are strong predictors of mortality in viral pneumonia.
- The gut-lipid-lung axis influences lipid profiles and inflammatory responses.
- Therapeutic strategies may include restoring lipid homeostasis with specialized pro-resolving mediators.
Guideline-Based Recommendations
Diagnosis
- Utilize serum lipid signatures as diagnostic indicators of disease severity.
Management
- Consider targeting lipid pathways for therapeutic intervention.
Monitoring & Follow-up
- Monitor lipid levels, particularly LDL-C and HDL-C, to assess disease progression.
Risks
- Be aware of the potential for systemic multi-organ dysfunction linked to lipidomic changes.
Patient & Prescribing Data
Patients hospitalized with severe viral pneumonia.
Restoring lipid homeostasis may improve clinical outcomes.
Clinical Best Practices
- Integrate lipidomic profiling into clinical assessments for patients with viral pneumonia.
- Evaluate the role of metabolic stabilizers and specialized pro-resolving mediators in treatment.
Related Resources & Content
